SC 13D Filing

Company

Celldex Therapeutics, Inc.

Filed

March 25, 2008

Accession Number

0001144204-08-017282

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →